Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide is approved as Mounjaro for diabetes and Zepbound for obesity
This in turn reduces the amount of insulin the body needs, ultimately resulting in reduced hyperglycemia and improved control of glucose levels
Patients who start with opioid-acetaminophen combinations for pain management are at an increased risk of developing long-term opioid dependence, reinforcing the need for caution when using these medications
The pricing applies to a new version of Lilly's weight-loss drug, Zepbound, that could come in a single, multi-dose penit currently is sold in differently dosed vials as patients start at low doses and work their way up to higher doses
US$ 23.07
US$ 21.89
US$ 22.60
US$ 28.65
